- Home
- PM vs NVS Comparison
PM vs NVS Comparison
Compare PM & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PM
- NVS
- Stock Information
- Founded
- PM 1987
- NVS 1895
- Country
- PM United States
- NVS Switzerland
- Employees
- PM N/A
- NVS N/A
- Industry
- PM Medicinal Chemicals and Botanical Products
- NVS Biotechnology: Pharmaceutical Preparations
- Sector
- PM Health Care
- NVS Health Care
- Exchange
- PM Nasdaq
- NVS Nasdaq
- Market Cap
- PM 283.9B
- NVS 230.5B
- IPO Year
- PM N/A
- NVS 1991
- Fundamental
- Price
- PM $183.21
- NVS $115.78
- Analyst Decision
- PM Strong Buy
- NVS Hold
- Analyst Count
- PM 12
- NVS 6
- Target Price
- PM $165.92
- NVS $123.67
- AVG Volume (30 Days)
- PM 4.9M
- NVS 1.2M
- Earning Date
- PM 07-22-2025
- NVS 07-17-2025
- Dividend Yield
- PM 2.96%
- NVS 3.45%
- EPS Growth
- PM N/A
- NVS N/A
- EPS
- PM 4.86
- NVS 6.38
- Revenue
- PM $38,386,000,000.00
- NVS $53,222,000,000.00
- Revenue This Year
- PM $11.78
- NVS $7.22
- Revenue Next Year
- PM $8.32
- NVS $1.94
- P/E Ratio
- PM $37.48
- NVS $18.14
- Revenue Growth
- PM 6.78
- NVS 11.50
- 52 Week Low
- PM $98.93
- NVS $96.06
- 52 Week High
- PM $186.69
- NVS $120.92
- Technical
- Relative Strength Index (RSI)
- PM 63.29
- NVS 51.61
- Support Level
- PM $181.56
- NVS $117.71
- Resistance Level
- PM $184.60
- NVS $120.92
- Average True Range (ATR)
- PM 3.04
- NVS 1.12
- MACD
- PM -0.39
- NVS -0.34
- Stochastic Oscillator
- PM 58.67
- NVS 8.87
About PM Philip Morris International Inc
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heatsticks, vapes, and oral nicotine offerings primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokeable products but also gained a toehold into the US to sell its iQOS heated tobacco product.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.